🇺🇸 FDA

Drug profile · INN

gadopentetate dimeglumine

MAGNEVIST

approved
US status
approved
Patents linked
0
News articles
0

Quick answer

gadopentetate dimeglumine (MAGNEVIST) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN gadopentetate dimeglumine
Brand MAGNEVIST
Route INJECTION
Formulation INJECTABLE

Frequently asked questions

What is gadopentetate dimeglumine?

gadopentetate dimeglumine (MAGNEVIST) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for gadopentetate dimeglumine?

MAGNEVIST is a marketed brand name for gadopentetate dimeglumine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of gadopentetate dimeglumine?

gadopentetate dimeglumine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.